Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Department of Endocrinology, Beijing Friendship Hospital Pinggu Campus, Capital Medical University, Beijing, China.
Diabetes Metab Res Rev. 2024 May;40(4):e3788. doi: 10.1002/dmrr.3788.
Alström syndrome (AS) is a rare recessive disorder characterised by diabetes, obesity, insulin resistance (IR), and visual and hearing impairments. Mutations in the ALMS1 gene have been identified as the causative agents of AS. This study aimed to explore the relationship between rare ALMS1 variants and clinical features in Chinese patients with early-onset type 2 diabetes (age at diagnosis ≤40 years; EOD).
ALMS1 gene sequencing was performed in 611 Chinese individuals with EOD, 36 with postprandial hyperinsulinemia, and 47 with pre-diabetes and fasting IR. In-silico prediction algorithm and the American College of Medical Genetics Guidelines (ACMG) were used to evaluate the deleteriousness and pathogenicity of the variants.
Sixty-two rare ALMS1 variants (frequency <0.005) were identified in 82 patients with EOD. Nineteen variants were predicted to be deleterious (pD). Patients with EOD carrying pD variants had higher fasting C-peptide, postprandial C-peptide, and HOMA2-IR levels than those without variants. The frequency of ALMS1 pD variants in the subgroup with more insulin-resistant EOD was higher than that in other EOD subgroups. Two patients with EOD, obesity, and IR who carried one heterozygous pathogenic/likely pathogenic rare variant of ALMS1 according to ACMG were identified. Moreover, rare heterozygous pD variants of ALMS1 were found in participants from cohorts of postprandial hyperinsulinemia as well as in pre-diabetes with fasting IR.
ALMS1 rare pD variants are enriched in the populations with significant IR, which is a major hallmark of diabetes pathogenesis. Accordingly, our exploratory study provides insights and hypotheses for further studies of gene function.
Alström 综合征(AS)是一种罕见的隐性疾病,其特征为糖尿病、肥胖、胰岛素抵抗(IR)以及视觉和听觉损伤。ALMS1 基因突变已被确定为 AS 的致病因素。本研究旨在探索中国早发 2 型糖尿病(诊断年龄≤40 岁;EOD)患者中罕见 ALMS1 变体与临床特征之间的关系。
对 611 例 EOD 患者、36 例餐后高胰岛素血症患者和 47 例糖尿病前期伴空腹 IR 患者进行了 ALMS1 基因测序。使用计算机预测算法和美国医学遗传学学院指南(ACMG)评估变体的有害性和致病性。
在 82 例 EOD 患者中发现了 62 种罕见的 ALMS1 变体(频率<0.005)。19 种变体被预测为有害(pD)。携带 pD 变体的 EOD 患者空腹 C 肽、餐后 C 肽和 HOMA2-IR 水平均高于无变体患者。在胰岛素抵抗更为严重的 EOD 亚组中,ALMS1 pD 变体的频率高于其他 EOD 亚组。两名携带 ALMS1 杂合致病性/可能致病性罕见 pD 变体的 EOD、肥胖和 IR 患者被确定。此外,在餐后高胰岛素血症队列以及空腹 IR 的糖尿病前期参与者中也发现了罕见的 ALMS1 杂合 pD 变体。
ALMS1 罕见的 pD 变体在具有显著 IR 的人群中更为丰富,IR 是糖尿病发病机制的主要标志。因此,我们的探索性研究为进一步研究基因功能提供了思路和假设。